Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
about
Propylthiouracil is teratogenic in murine embryosPatient knowledge of antithyroid drug-induced agranulocytosisSide effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancySuspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy.Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature.High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article.The safety and efficacy of antithyroid drugs.Peripheral blood lymphocyte apoptosis and its relationship with thyroid function tests in adolescents with hyperthyroidism due to Graves' disease.Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in KoreaImpact of methimazole treatment on magnesium concentration and lymphocytes activation in adolescents with Graves' disease.The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Treatment options in the young patient with Graves' disease.Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole.2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
P2860
Q28482407-18CD2C0D-FE86-4A8C-B7A5-CBB2D17B7BAFQ35029667-093933F5-6A67-45CA-9677-C0312F7A47DBQ35160028-3B7E9B29-CFE1-4E1F-A889-E001530CB917Q35212812-C6714210-8C2D-4BE9-89C6-FDE09D661617Q35594705-B357DA25-5CED-4D9F-9F90-037B29107FACQ36194164-4EF98CBB-6F9E-4AF9-A678-04104FF0206FQ36349745-676E8E21-F09B-4460-93C0-581913597476Q36423062-766BED79-6050-4691-9774-52D661305CE5Q36489118-DE9310C4-5811-4F1B-BF25-B6E037658F9AQ36886212-A84D2D7F-FBBF-4E32-ADDF-201A0B9B1294Q38107399-F02F9354-3478-4F64-B431-D54C44FC5D83Q38562400-46ADB817-4C8F-4C34-82F7-2B13E1972382Q40465857-63F9E68E-FC27-4414-8DD7-6CC36C1BA455Q57136607-FBB5BE21-DD08-48CE-917B-9A9F6A9C8BC2
P2860
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
@en
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
@nl
type
label
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
@en
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
@nl
prefLabel
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
@en
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
@nl
P2860
P1476
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
@en
P2093
Simon H S Pearce
P2860
P304
P356
10.1111/J.1365-2265.2004.02135.X
P577
2004-11-01T00:00:00Z